These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
114 related articles for article (PubMed ID: 7184034)
1. Nutritional iron and dopamine binding sites in the rat brain. Ashkenazi R; Ben-Shachar D; Youdim MB Pharmacol Biochem Behav; 1982; 17 Suppl 1():43-7. PubMed ID: 7184034 [TBL] [Abstract][Full Text] [Related]
2. Prevention of neuroleptic-induced dopamine D2 receptor supersensitivity by chronic iron salt treatment. Ben-Shachar D; Pinhassi B; Youdim MB Eur J Pharmacol; 1991 Sep; 202(2):177-83. PubMed ID: 1687031 [TBL] [Abstract][Full Text] [Related]
3. Long-term consequence of early iron-deficiency on dopaminergic neurotransmission in rats. Ben-Shachar D; Ashkenazi R; Youdim MB Int J Dev Neurosci; 1986; 4(1):81-8. PubMed ID: 2844061 [TBL] [Abstract][Full Text] [Related]
4. Neuroleptic-induced supersensitivity and brain iron: I. Iron deficiency and neuroleptic-induced dopamine D2 receptor supersensitivity. Ben-Shachar D; Youdim MB J Neurochem; 1990 Apr; 54(4):1136-41. PubMed ID: 1968955 [TBL] [Abstract][Full Text] [Related]
5. Effect of iron chelators on dopamine D2 receptors. Ben-Shachar D; Finberg JP; Youdim MB J Neurochem; 1985 Oct; 45(4):999-1005. PubMed ID: 2993525 [TBL] [Abstract][Full Text] [Related]
6. Repeated D1 dopamine receptor agonist administration prevents the development of both D1 and D2 striatal receptor supersensitivity following denervation. Hu XT; White FJ Synapse; 1992 Mar; 10(3):206-16. PubMed ID: 1532677 [TBL] [Abstract][Full Text] [Related]
7. Brain iron and dopamine receptor function. Youdim MB; Ben-Shachar D; Ashkenazi R; Yehuda S Adv Biochem Psychopharmacol; 1983; 37():309-21. PubMed ID: 6138953 [TBL] [Abstract][Full Text] [Related]
8. RDS-127 (2-di-n-propylamino-4,7-dimethoxyindane): central effects of a new dopamine receptor agonist. Arnerić SP; Long JP; Williams M; Goodale DB; Mott J; Lakoski JM; Gebhart GF J Pharmacol Exp Ther; 1983 Jan; 224(1):161-70. PubMed ID: 6401334 [TBL] [Abstract][Full Text] [Related]
9. Brain iron: a lesson from animal models. Yehuda S; Youdim MB Am J Clin Nutr; 1989 Sep; 50(3 Suppl):618-25; discussion 625-9. PubMed ID: 2570524 [TBL] [Abstract][Full Text] [Related]
10. Iron deficiency alters discrete proteins in rat caudate nucleus and nucleus accumbens. Youdim MB; Sills MA; Heydorn WE; Creed GJ; Jacobowitz DM J Neurochem; 1986 Sep; 47(3):794-9. PubMed ID: 2942640 [TBL] [Abstract][Full Text] [Related]
11. Pharmacological profiles of the putative dopamine autoreceptor agonists 3-PPP and TL-99. Martin GE; Haubrich DR; Williams M Eur J Pharmacol; 1981 Nov; 76(1):15-23. PubMed ID: 7318920 [TBL] [Abstract][Full Text] [Related]
12. Behavioural evidence for supersensitivity of postsynaptic dopamine receptors in the mesolimbic system after chronic administration of desipramine. Spyraki C; Fibiger HC Eur J Pharmacol; 1981 Sep; 74(2-3):195-206. PubMed ID: 7198991 [TBL] [Abstract][Full Text] [Related]
13. Effects of chronic lithium treatment on dopamine receptors in the rat corpus striatum. II. No effect on denervation or neuroleptic-induced supersensitivity. Staunton DA; Magistretti PJ; Shoemaker WJ; Deyo SN; Bloom FE Brain Res; 1982 Jan; 232(2):401-12. PubMed ID: 6322915 [TBL] [Abstract][Full Text] [Related]
14. Effects of pertussis toxin on D2-dopamine receptor in rat striatum: evidence for coupling of Ni regulatory protein with D2-receptor. Fujita N; Nakahiro M; Fukuchi I; Saito K; Yoshida H Brain Res; 1985 May; 333(2):231-6. PubMed ID: 3158374 [TBL] [Abstract][Full Text] [Related]
15. Possible involvement of pertussis toxin-sensitive G proteins and D2 dopamine receptors in the A1 adenosine receptor-adenylate cyclase system in rat cerebral cortex. Murayama T; Itahashi Y; Nomura Y J Neurochem; 1990 Nov; 55(5):1631-8. PubMed ID: 2145396 [TBL] [Abstract][Full Text] [Related]